Table 3

Multivariate predictive model for factors influencing physicians decision on anaphylaxis diagnosis and first-line management choice. Statistically significant difference (p<0.05) appear in bold

Respondents characteristicDiagnosed patient with anaphylaxis, %OR (95% CI)p ValueUsed adrenalin 1:1000 intramuscular, %OR (95% CI)p ValueUsed prednisolone intramuscular, %OR (95% CI)p ValueUsed chloropyramine, %OR (95% CI)p Value
Clinical settings
Primary care/private practice
Secondary and/or
tertiary care
29
41
0.59 (0.36 to 0.98) 0.04 13
18
0.68 (0.35 to 1.29)0.2341
30
1.60 (0.96 to 2.66)0.0727
24
1.18 (0.69 to 2.050.54
Clinical experience (years)
1–10
>10
32
34
0.92 (0.50 to 1.69)0.7915
15
0.99 (0.45 to 2.20)0.9938
37
1.07 (0.60 to 1.91)0.8328
26
1.13 (0.60 to 2.12)0.71
Specialty
Paediatrics
341.22
0.46161.36 (0.67 to 2.77)0.4039
32
1.36 (0.82 to 2.28)0.2329
22
1.43 (0.81 to 2.53)0.22
Other specialities 30(0.72 to 2.05)13